MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis

[1]  D. Reich,et al.  MYH9 is associated with nondiabetic end-stage renal disease in African Americans , 2008, Nature Genetics.

[2]  M. Nalls,et al.  Admixture mapping of white cell count: genetic locus responsible for lower white blood cell count in the Health ABC and Jackson Heart studies. , 2008, American journal of human genetics.

[3]  David Reich,et al.  Discerning the Ancestry of European Americans in Genetic Association Studies , 2007, PLoS genetics.

[4]  J. Coresh,et al.  Prevalence of chronic kidney disease in the United States. , 2007, JAMA.

[5]  P. Kimmel,et al.  NPHS2 variation in sporadic focal segmental glomerulosclerosis. , 2007, Journal of the American Society of Nephrology.

[6]  Zhaohui S. Qin,et al.  A second generation human haplotype map of over 3.1 million SNPs , 2007, Nature.

[7]  R. Wiggins,et al.  The spectrum of podocytopathies: a unifying view of glomerular diseases. , 2007, Kidney international.

[8]  J. Reveille,et al.  A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE. , 2007, Arthritis and rheumatism.

[9]  H. Schnaper,et al.  A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases. , 2007, Clinical journal of the American Society of Nephrology : CJASN.

[10]  P. Fearnhead,et al.  Genome-wide association study of prostate cancer identifies a second risk locus at 8q24 , 2007, Nature Genetics.

[11]  A. Reiner,et al.  Admixture mapping of an allele affecting interleukin 6 soluble receptor and interleukin 6 levels. , 2007, American journal of human genetics.

[12]  A. Whittemore,et al.  Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men , 2006, Proceedings of the National Academy of Sciences.

[13]  Yasuhiko Tomino,et al.  Synaptopodin orchestrates actin organization and cell motility via regulation of RhoA signalling , 2006, Nature Cell Biology.

[14]  Gudmundur A. Thorisson,et al.  The International HapMap Project Web site. , 2005, Genome research.

[15]  David Reich,et al.  A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibility , 2005, Nature Genetics.

[16]  D. Reich,et al.  Will admixture mapping work to find disease genes? , 2005, Philosophical Transactions of the Royal Society B: Biological Sciences.

[17]  M. Kelley,et al.  Genotype–phenotype correlation in MYH9‐related thrombocytopenia , 2005, British journal of haematology.

[18]  Hua Tang,et al.  Estimation of individual admixture: Analytical and study design considerations , 2005, Genetic epidemiology.

[19]  D. Vlahov,et al.  Variants in the Wilms' tumor gene are associated with focal segmental glomerulosclerosis in the African American population. , 2005, Physiological genomics.

[20]  N. Risch,et al.  Admixture mapping for hypertension loci with genome-scan markers , 2005, Nature Genetics.

[21]  T. Naoe,et al.  Targeted disruption of mouse ortholog of the human MYH9 responsible for macrothrombocytopenia with different organ involvement: hematological, nephrological, and otological studies of heterozygous KO mice. , 2004, Biochemical and biophysical research communications.

[22]  R. Toto.  Proteinuria and hypertensive nephrosclerosis in African Americans. , 2004, Kidney international. Supplement.

[23]  P. Eggers,et al.  Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[24]  C. Langefeld,et al.  A genome scan for ESRD in black families enriched for nondiabetic nephropathy. , 2004, Journal of the American Society of Nephrology : JASN.

[25]  C. Langefeld,et al.  A genome scan for diabetic nephropathy in African Americans. , 2004, Kidney international.

[26]  P. Kimmel,et al.  Is there an epidemic of HIV Infection in the US ESRD program? , 2004, Journal of the American Society of Nephrology : JASN.

[27]  Stephen J O'Brien,et al.  Human genes that limit AIDS , 2004, Nature Genetics.

[28]  Scott M. Williams,et al.  A high-density admixture map for disease gene discovery in african americans. , 2004, American journal of human genetics.

[29]  M. Daly,et al.  Methods for high-density admixture mapping of disease genes. , 2004, American journal of human genetics.

[30]  N. Powe.  To have and have not: Health and health care disparities in chronic kidney disease. , 2003, Kidney international.

[31]  M. Winn.  Approach to the evaluation of heritable diseases and update on familial focal segmental glomerulosclerosis. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[32]  E. Unanue,et al.  CD2-Associated Protein Haploinsufficiency Is Linked to Glomerular Disease Susceptibility , 2003, Science.

[33]  M. Olivier.  A haplotype map of the human genome , 2003, Nature.

[34]  P. Eggers,et al.  Trends in the epidemiology of focal segmental glomerulosclerosis. , 2003, Seminars in nephrology.

[35]  C. Winkler,et al.  HIV-associated nephropathy in African Americans1 , 2003 .

[36]  C. Marcantoni,et al.  Hypertensive nephrosclerosis in African Americans versus Caucasians. , 2002, Kidney international.

[37]  B. Kiberd,et al.  Cumulative risk for developing end-stage renal disease in the US population. , 2002, Journal of the American Society of Nephrology : JASN.

[38]  S. Gabriel,et al.  The Structure of Haplotype Blocks in the Human Genome , 2002, Science.

[39]  S. Iyengar,et al.  Inaccuracy of clinical phenotyping parameters for hypertensive nephrosclerosis. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[40]  J. Sellers,et al.  Myosins: a diverse superfamily. , 2000, Biochimica et biophysica acta.

[41]  J. Kaplan,et al.  Mutations in ACTN4, encoding α-actinin-4, cause familial focal segmental glomerulosclerosis , 2000, Nature Genetics.

[42]  P. Klotman,et al.  Pathogenesis of human immunodeficiency virus (HIV)-associated nephropathy. , 1998, Seminars in nephrology.

[43]  L. Excoffier,et al.  Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. , 1995, Molecular biology and evolution.

[44]  B. Freedman,et al.  The link between hypertension and nephrosclerosis. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[45]  P. Savage,et al.  Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. , 1989, The New England journal of medicine.

[46]  Xiaofeng Zhu,et al.  Admixture mapping and the role of population structure for localizing disease genes. , 2008, Advances in genetics.

[47]  R. Ravazzolo,et al.  Genetics, clinical and pathological features of glomerulonephritis associated with mutations of nonmuscle myosin IIA (Fechtner syndrome). , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[48]  Corinne Antignac,et al.  Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes. , 2002, Journal of the American Society of Nephrology : JASN.

[49]  J. Breyer,et al.  Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators. , 1997, Kidney international.

[50]  M. Stephens,et al.  Accounting for Decay of Linkage Disequilibrium in Haplotype Inference and Missing-data Imputation , 2022 .